Two drugs from Massachusetts biotechs win FDA approval

Two drugs from Massachusetts biotechs win FDA approval


Two experimental therapies hatched in the labs of Massachusetts biotechs won Food and Drug Administration approval Friday to be sold in the United States. Federal regulators used an accelerated approval process to green-light a targeted small-molecule lung cancer drug, developed by Ariad Pharmaceuticals Inc. before the Cambridge-based company was sold earlier this year to Japan's Takeda Pharmaceuticals Inc. Also approved, two months before the FDA's scheduled decision date, was a hormone treatment developed by Radius Health Inc .



from Biotech News